Panacea Life Sciences Holdings, Inc. (PLSH)

USD 0.06

(0.0%)

Market Cap (In USD)

1.23 Million

Revenue (In USD)

2.38 Million

Net Income (In USD)

-8.01 Million

Avg. Volume

1045.00

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
0.0384-0.35
PE
-
EPS
-
Beta Value
3.199
ISIN
US69810P1093
CUSIP
69810P109
CIK
1552189
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Ms. Leslie A. Buttorff
Employee Count
-
Website
https://www.panacealife.com
Ipo Date
2022-04-04
Details
Panacea Life Sciences Holdings, Inc., a seed to sale cannabinoid and nutraceutical manufacturer and research company, develops and produces natural pharmaceutical alternatives for consumers and pets. The company manufactures and sells softgels, gummies, tinctures, sublingual tablets, cosmetics, and other topicals. It is also involved in the personal protection equipment (PPE) business, including importing and selling PPE hand sanitizers and masks, as well as white label and contract manufacturing sales to other cannabinoid companies, raw material sales, and tolling arrangements. The company was incorporated in 2008 and is headquartered in Greenwood Village, Colorado.